PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA. (23rd June 2022) - Krishnan, A.; Nooka, A. K.; Chari, A.; Garfall, A.; Martin, T.; Nair, S.; Lin, X.; Qi, K.; Londhe, A.; Pei, L.; Ammann, E.; Kobos, R.; et al.